Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Emerging Approaches in Schizophrenia
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Lina Góez-Mogollón, MD, MSc
JCP
Original Research
Risk of PNAS in SGA-Exposed Infants
January 4, 2023
Roughly 30% of infants exposed to SGAs in utero exhibited poor neonatal adaptation syndrome; the percentage among antidepressant-exposed infants was similar.
Adele C. Viguera
,
Sara A. McElheny
,
Phoebe S. Caplin
, et al
JCP
Correction
Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
October 5, 2021
Adele C. Viguera
,
Marlene P. Freeman
,
Lina Góez-Mogollón
, et al
JCP
Original Research
Reproductive Safety of Second-Generation Antipsychotics
August 3, 2021
What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
Adele C. Viguera
,
Marlene P. Freeman
,
Lina Góez-Mogollón
, et al
